Natera (NTRA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

NTRA Natera

Watchlist

173.390
+2.660+1.56%

Close Feb 14 16:00 ET

176.000
+2.610+1.51%

Post 20:01 ET

22.89BMarket Cap-98.52P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Raymond James Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $175
Moomoo NewsFeb 10 14:31 ET · Ratings
Express News | Live On CNBC, Amy Raskin Announces Trimmed Vertex Pharmaceuticals ; Trimmed Kadant Position; Trimmed Natera Position; Bought CareDx
BenzingaFeb 10 12:44 ET
Natera Comments on Updated NCCN Guidance for Circulating Tumor DNA
TipRanksFeb 10 07:20 ET
Express News | Nccn Strengthens Guidance on Ctdna in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
ReutersFeb 10 07:00 ET
NCCN Strengthens Guidance on CtDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
NateraFeb 10 00:00 ET
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
BenzingaFeb 6 10:15 ET

Comments

Teddy123

Feb 10 06:16

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

$Natera (NTRA.US)$
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection

In One Chart

Nov 15, 2024 04:22

Columns Top Institutions Continue to Hold Strong Tech Positions in Q3 13F Filings

The recent release of 13F reports from institutional investors has shed light on the shifting sands of Wall Street's investment landscape. These mandatory filings, required by the U.S. Securities and Exchange Commission (SEC) for institutions managing over $100 million in equity assets, provide a window into the portfolio adjustments of the financial world's heavyweights, including the likes of Berkshire Hathaway, Baillie G...

Warren Buffett boosted stake: Can OXY's Q3 earnings pump its price?

Brianjh

Oct 17, 2024 09:21

Druckenmiller Stock Portfolio

Stanley Druckenmiller says he's ‘licking my wounds’ from selling Nvidia too soon
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...